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Summary
Toll-like receptors (TLRs) are pattern recognition
receptors that recognize conserved molecular pat-
terns expressed by pathogens. Pneumolysin, an intra-
cellular toxin found in all Streptococcus pneumoniae
clinical isolates, is an important virulence factor of the
pneumococcus that is recognized by TLR4. Although
TLR2 is considered the most important receptor for
Gram-positive bacteria, our laboratory previously
could not demonstrate a decisive role for TLR2 in host
defence against pneumonia caused by a serotype 3
S. pneumoniae. Here we tested the hypothesis that in
the absence of TLR2, S. pneumoniae can still be
sensed by the immune system through an interaction
between pneumolysin and TLR4. C57BL/6 wild-type
(WT) and TLR2 knockout (KO) mice were intranasally
infected with either WT S. pneumoniae D39 (serotype
2) or the isogenic pneumolysin-deﬁcient S. pneumo-
niae strain D39 PLN. TLR2 did not contribute to anti-
bacterial defence against WT S. pneumoniae D39.
In contrast, pneumolysin-deﬁcient S. pneumoniae
only grew in lungs of TLR2 KO mice. TLR2 KO mice
displayed a strongly reduced early inﬂammatory
response in their lungs during pneumonia caused
by both pneumolysin-producing and pneumolysin-
deﬁcient pneumococci. These data suggest that
pneumolysin-induced TLR4 signalling can compen-
sate for TLR2 deﬁciency during respiratory tract infec-
tion with S. pneumoniae.
Introduction
Streptococcus pneumoniae is the most common cause
of community-acquired pneumonia (Bernstein, 1999;
Campbell, 1999). Infections caused by S. pneumoniae
are increasingly difficult to treat due to the emergence of
antibiotic-resistant strains (Pikis et al., 1995; Schreiber
and Jacobs, 1995). Increased knowledge of the ﬁrst inter-
action between S. pneumoniae and host immune cells
may facilitate the development of novel prophylactic and
therapeutic tools to combat pneumococcal infections. In
this respect, Toll-like receptors (TLRs), a family of pattern
recognition receptors that are capable of recognizing con-
served molecular patterns expressed by pathogens, are
of particular interest (Kawai and Akira, 2005; Paterson
and Mitchell, 2006).
The pneumococcal cell wall consists of several proteins
and enzymes that contribute to the virulence of the patho-
gen and the pathogenesis of pneumonia (Jedrzejas,
2001). Pneumolysin is an intracellular toxin found in
S. pneumoniae, which is produced by all clinical isolates
and is an important factor for the virulence of the pneu-
mococcus (Hirst et al., 2004). Indeed, mice infected with a
pneumolysin-deﬁcient strain of S. pneumoniae showed a
reduced lethality and a diminished inﬂammatory response
compared with mice infected with a normal, pneumolysin-
producing strain (Berry et al., 1989; Benton et al., 1995;
Canvin et al., 1995; Rubins et al., 1995; Berry and Paton,
2000; Kadioglu et al., 2002). At sublytic dose, pneumol-
ysin affects polymorphonuclear cell activity, including res-
piratory burst, degranulation, chemotaxis and bactericidal
activity (Paton and Ferrante, 1983). Furthermore, pneu-
molysin activates the classical pathway of complement
and induces cytokine production by macrophages and
monocytes (Houldsworth et al., 1994; Paton, 1996; Cock-
eran et al., 2002). At lytic dose, pneumolysin forms ring-
shaped pores in cholesterol-containing cell membranes,
which results in cell death (Alouf, 2000; Gilbert, 2002).
Recent work has suggested that the immune system rec-
ognizes pneumolysin through TLR4 (Malley et al., 2003;
Srivastava et al., 2005). Both pneumolysin-induced cytok-
ine production and pneumolysin-induced apoptosis are
mediated through TLR4 (Malley et al., 2003; Srivastava
et al., 2005). In a model of nasopharyngeal colonization
by S. pneumoniae, the interaction between pneumolysin
and TLR4 was found to be essential for preventing
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reported a protective role of TLR4 during infection of the
lower respiratory tract by S. pneumoniae, demonstrating
an enhanced growth of bacteria in lungs of TLR4-deﬁcient
mice (Branger et al., 2004).
Within the family of TLRs, TLR2 has been implicated as
the major pattern recognition receptor for ligands derived
from Gram-positive bacteria (Yoshimura et al., 1999; Han
et al., 2003; Schroder et al., 2003; Kawai and Akira,
2005). However, our laboratory recently demonstrated
that TLR2 does not play a key role in host resistance
to pneumonia caused by a serotype 3 strain of
S. pneumoniae (Knapp et al., 2004). We here hypoth-
esized that TLR2 knockout (KO) mice have an intact
protective immune response against S. pneumoniae,
because they are still capable of activating their immune
system through an interaction between pneumolysin
and TLR4. If this assumption is true, TLR2 KO mice
would display a reduced antibacterial defence against
pneumolysin-deﬁcient S. pneumoniae, considering that
these modiﬁed bacteria, devoid of a major TLR4 ligand,
would primarily express TLR2 ligands. Therefore, in the
present study we compared the response of TLR2 KO and
wild-type (WT) mice during respiratory tract infection with
WT and pneumolysin-deﬁcient S. pneumoniae.
Results
Toll-like receptor 2 does not contribute to host defence
and pulmonary inﬂammation against pneumonia caused
by WT S. pneumoniae D39
We previously showed that TLR2 KO mice are indistin-
guishable from WT mice with regard to bacterial out-
growth and mortality after intranasal infection with a
serotype 3 S. pneumoniae strain (Knapp et al., 2004).
Considering that the pneumolysin-deﬁcient strain used
here is a serotype 2 (derived from S. pneumoniae D39),
we ﬁrst investigated the impact of TLR2 deﬁciency on the
course of pneumonia caused by WT S. pneumoniae D39
(Fig. 1). Mortality did not differ between TLR2 KO and WT
mice after intranasal infection with S. pneumoniae D39; if
anything, TLR2 KO mice displayed a slightly reduced
mortality (62.5%) although the difference with WT mice
(75% mortality) was not signiﬁcant (P = 0.13; Fig. 1A). We
next determined bacterial loads in whole lung homoge-
nates at 24 and 48 h after infection, i.e. at time points just
before the ﬁrst mice started dying (Fig. 1B). At both 24
and 48 h, bacterial loads were identical in lungs of TLR2
KO and WT mice. Together these data extend our earlier
study using a serotype 3 S. pneumoniae strain (Knapp
et al., 2004), showing that TLR2 does not contribute to a
protective immune response during pneumonia caused
by a serotype 2 pneumococcus.
Toll-like receptor 2 (TLR2) deﬁciency modestly
attenuates the inﬂammatory response induced by
WT S. pneumoniae D39
Cytokines and chemokines play an important role in the
antibacterial defence against bacterial pneumonia (Moore
and Standiford, 2001; Knapp et al., 2005). We therefore
determined the concentrations of tumour necrosis factor
(TNF)-a, interleukin (IL)-1b, IL-10, macrophage inﬂamma-
tory protein (MIP)-2 and cytokine-induced neutrophil
chemoattractant (KC) in whole lung homogenates
obtained 24 and 48 h after inoculation (Table 1). Although
in general the pulmonary concentrations of these media-
tors were lower in TLR2 KO mice, the differences with WT
mice were statistically signiﬁcant only for KC (P < 0.005 at
24 and 48 h post infection) and IL-1b (P < 0.05 at 48 h). To
further investigate lung inﬂammation, we determined
Fig. 1. TLR2 does not contribute to host defence against WT
S. pneumoniae. Survival (A) and bacterial outgrowth (B) of WT
mice (closed symbols or bars) and TLR2 KO mice (open symbols
or bars) with 5 ¥ 10
7 cfu S. pneumoniae D39. Mortality was
assessed four times daily for 14 days (n = 16 per group). Bacterial
loads in WT mice and TLR2 KO mice were determined 24 and 48 h
after infection. Data of bacterial loads are mean  SEM (n = 7–8
per group at each time point).
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whole-organ neutrophil content, in TLR2 KO mice and WT
mice (Table 1). Similar to cytokine and chemokine levels,
MPO concentrations were modestly lower in TLR2 KO,
signiﬁcantly so at 48 h post infection (P < 0.01). Moreover,
total lung inﬂammation scores, determined from lung
tissue slides prepared 24 and 48 h after infection with
S. pneumoniae D39, were similar in WT and TLR2 KO
mice (Table 1). Together, these data obtained with a sero-
type 2 pneumococcus conﬁrm our earlier data generated
with a serotype 3 S. pneumoniae (Knapp et al., 2004),
establishing that TLR2 plays a modest role in the induc-
tion of a pulmonary inﬂammatory response to respiratory
tract infection with WT S. pneumoniae.
Toll-like receptor 2 limits the outgrowth of
pneumolysin-deﬁcient S. pneumoniae PLN
Having established that TLR2 is not essential for host
defence against WT S. pneumoniae D39, we next
infected TLR2 KO and WT mice with the isogenic mutant
S. pneumoniae PLN (Fig. 2). As expected (Berry et al.,
1989), S. pneumoniae PLN was less virulent, in particular
in WT mice. Only 23% of WT mice died during a 2 week
follow-up, versus 38% of TLR2 KO mice (not signiﬁcant
for the difference between mouse strains; P = 0.29;
Fig. 2A). Interestingly, TLR2 KO mice started to die after
3 days, whereas the ﬁrst deaths among WT mice
occurred after 5 days. To obtain insight in the growth of
S. pneumoniae PLN during the infection (i.e. before the
ﬁrst mice started dying), we infected TLR2 KO and WT
mice with S. pneumoniae PLN and determined bacterial
loads in whole lung homogenates at 24, 48 and 72 h
thereafter (Fig. 2B). Whereas the bacterial burdens were
not signiﬁcantly different between TLR2 KO and WT mice
24 h post infection, at 48 and 72 h TLR2 KO displayed
signiﬁcantly higher bacterial loads in their lungs than
WT mice (both P < 0.05). Remarkably, whereas
S. pneumoniae PLN did not further grow in the lungs of
WT mice from 24 h after infection onward, which is in line
with a previous investigation (Canvin et al., 1995), the
bacterial load increased more than 10-fold in lungs of
TLR2 KO mice between 24 and 72 h after inoculation.
Table 1. Parameters of lung inﬂammation in TLR2 KO and WT mice 24 and 48 h after infection with WT S. pneumoniae D39.
24 h 48 h
WT TLR2 KO WT TLR2 KO
TNF-a 1229  351 1026  212 500  92 361  63
IL-1b 4029  599 3248  495 2874  594 1462  329*
IL-10 62  23 48  14 123  51 72  13
MIP-2 5912  876 5689  1039 1447  177 1182  243
KC 5943  867 2244  510** 3481  339 695  90**
MPO 7668  1123 6158  2317 9183  2365 4057  578***
TLIS 16.7  0.9 16.8  1.0 13.5  0.6 15.5  0.8
Mice were intranasally infected with 5 ¥ 10
7 cfu WT S. pneumoniae D39; whole lung homogenates were obtained 24 and 48 h thereafter. Data are
means  SEM (n = 6–8 per group).
*P < 0.05 versus WT mice. **P < 0.005 versus WT mice. ***P < 0.01 versus WT mice.
TNF-a, IL-1b, IL-10, MIP-2 and KC values are in pg ml
-1; MPO values are in ng ml
-1; TLIS (total lung inﬂammation score) in arbitrary units.
Fig. 2. TLR2 limits outgrowth of pneumolysin-deﬁcient
S. pneumoniae PLN. Survival (A) and bacterial outgrowth (B) of WT
mice (closed symbols or bars) and TLR2 KO mice (open symbols
or bars) with 5 ¥ 10
7 cfu S. pneumoniae PLN. Mortality was
assessed four times daily for 14 days (n = 13 per group). Bacterial
loads in WT mice and TLR2 KO mice were determined 24, 48 and
72 h after infection. Data of bacterial loads are mean  SEM
(n = 7–8 per group at each time point) *P < 0.05 versus WT mice.
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growth of S. pneumoniae PLN during pneumonia.
Toll-like receptor 2 (TLR2) deﬁciency reduces lung
inﬂammation induced by S. pneumoniae PLN
To further investigate the role of TLR2 during infection with
S. pneumoniae PLN, we determined TNF-a, IL-1b, IL-10,
MIP-2, KC and MPO levels in whole lung homogenates
obtained 24, 48 and 72 h after inoculation (Table 2). At
24 h post infection, pulmonary cytokine and chemokine
levels were lower in TLR2 KO mice, signiﬁcantly so for
IL-1b (P < 0.05). In addition, lung MPO levels were lower
in TLR2 KO mice at this time point (P < 0.05). In contrast,
at 48 and 72 h after infection, when TLR2 KO mice dis-
played higher bacterial burdens in their lungs, the pulmo-
nary concentrations of cytokines, chemokines and MPO
did not differ between TLR2 KO and WT mice. Histopatho-
logical analyses of lung tissue slides demonstrated
reduced lung inﬂammation in TLR2 KO mice at 24 h, but
increased lung inﬂammation at 48 and 72 h (Table 2).
Representative lung tissue slides from WT and TLR2 KO
mice 24, 48 and 72 h after infection with S. pneumoniae
PLN are shown in Fig. 3.
Toll-like receptor 2 (TLR2) deﬁciency strongly impairs
the early inﬂammatory response to both S. pneumoniae
D39 and S. pneumoniae PLN
The role of TLR2 in lung inﬂammation later in the course
of pneumonia could have been obscured by the growing
bacterial load in TLR2 KO mice (that is, at 48 and 72 h
after infection, TLR2 deﬁciency could be compensated
for by the higher bacterial load, providing a more potent
proinﬂammatory stimulus via TLR2-independent path-
ways). An earlier study performed at our laboratory has
shown an important role for TLR2 in the early host
defence against S. pneumoniae pneumonia using sero-
type 3 (Knapp et al., 2004). TLR2 could also be more
important for the early host inﬂammatory response to
S. pneumoniae with serotype 2. Thus, we intranasally
inoculated TLR2 KO and WT mice with S. pneumoniae
D39 or S. pneumoniae PLN and evaluated their
response to the infection 6 h later (Table 3). The bacte-
rial loads in lungs of TLR2 KO mice and WT mice were
similar at this early time point during infection with
S. pneumoniae D39 or S. pneumoniae PLN. Interest-
ingly, compared with WT mice, TLR2 KO mice showed a
strongly reduced capacity to respond to both S. pneu-
moniae D39 and S. pneumoniae PLN; the lung concen-
trations of TNF-a, IL-1b, MIP-2 and KC were much lower
in TLR2 KO mice (P < 0.05 to P < 0.001) (Table 3). In
addition, histopathological analyses of lung tissue slides
demonstrated a signiﬁcantly reduced inﬂammation in
lungs of TLR2 KO mice 6 h after infection with S. pneu-
moniae D39 or S. pneumoniae PLN (Fig. 4). Of note,
some inﬂammatory responses to S. pneumoniae PLN
were more strongly reduced in TLR2 KO mice than the
inﬂammatory responses to S. pneumoniae D39. For KC,
MIP-2 and TNF-a, there was a signiﬁcant interaction
(P < 0.001, P = 0.034 and P = 0.007, respectively); the
effect of the pneumococcal strain used depended on the
mouse strain. In particular, whereas in WT mice S. pneu-
moniae D39 and PLN induced a similar early TNF-a
response in the lungs, the pulmonary levels of this
crucially protective cytokine in the early response to
pneumococcal pneumonia (van der Poll et al., 1997;
Rijneveld et al., 2001) were more than 4-fold lower in
TLR2 KO mice after infection with S. pneumoniae PLN
versus 2-fold lower after inoculation with S. pneumoniae
D39. In addition, whereas overall S. pneumoniae PLN
elicited less profound histopathological alterations in
lung tissue than S. pneumoniae D39, the difference in
total lung histology scores between TLR2 KO and WT
mice was especially clear after infection with the
pneumolysin-deﬁcient strain.
Table 2. Parameters of lung inﬂammation in TLR2 KO and WT mice 24, 48 and 72 h after infection with pneumolysin-deﬁcient S. pneumoniae
PLN.
24 h 48 h 72 h
WT TLR2 KO WT TLR2 KO WT TLR2 KO
TNF-a 325  77 295  87 195  34 195  34 506  114 522  163
IL-1b 2414  519 903  496* 552  215 802  200 1724  638 2092  956
IL-10 BD BD BD BD 135  27 153  63
MIP-2 2703  1033 1956  1001 1919  194 2720  649 1029  589 1297  692
KC 1781  791 600  158 1700  980 610  188 1385  323 958  391
MPO 3173  391 1666  411* 1675  424 2205  226 2722  251 2402  500
TLIS 7.7  2.0 3.1  1.2 6.9  1.6 11.9  2.1 5.6  0.9 8.7  0.8*
Mice were intranasally infected with 5 ¥ 10
7 cfu S. pneumoniae PLN; whole lung homogenates were obtained 24, 48 and 72 h thereafter. Data are
means  SEM (n = 6–8 per group).
*P < 0.05 versus WT mice.
TNF-a, IL-1b, IL-10, MIP-2 and KC values are in pg ml
-1; MPO values are in ng ml
-1; TLIS (total lung inﬂammation score) in arbitrary units.
BD, below detection limit.
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Pneumolysin is an essential virulence factor of
S. pneumoniae (Hirst et al., 2004). Recent studies have
identiﬁed TLR4 as a recognition receptor for pneumolysin
in the respiratory tract (Malley et al., 2003; Srivastava
et al., 2005). The interaction between pneumolysin and
TLR4 was found to contribute to a protective immune
Fig. 3. Lung histology in WT and TLR2 KO mice after infection with S. pneumoniae PLN. Representative lung tissue slides from WT mice
(A, C and E) and TLR2 KO mice (B, D and F) after infection with 5 ¥ 10
7 cfu S. pneumoniae PLN. Mice were sacriﬁced after 24 h (A and B),
48 h (C and D) or 72 h (E and F). HE staining: magniﬁcation 4¥.
TLR2 and pneumolysin-deﬁcient S. pneumoniae 241
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 10, 237–246Table 3. Role of TLR2 in the early inﬂammatory response in the lungs after infection with S. pneumoniae D39 or PLN.
D39 PLN
WT TLR2 KO WT TLR2 KO
cfu 6.5  1.4 ¥ 10
6 5.5  1.3 ¥ 10
6 13.2  1.3 ¥ 10
6 10.6  1.8 ¥ 10
6
TNF-a 9 781  780 4 656  375** 9 124  1 203 2270  236**
IL-1b 5 754  714 3 566  348* 18 963  2 522 8716  1939*
IL-10 31  23 2  3B D B D
MIP-2 42 193  2 529 23 855  3 396*** 9 114  1 112 2643  505**
KC 61 120  2 879 23 266  3 124*** 16 776  2 314 4783  1352**
MPO 76.7  9.3 41.6  3.4* 15.5  3.4 12.4  4.0
TLIS 18.4  0.5 15.1  0.8* 9.5  0.9 5.3  1.3*
Mice were intranasally infected with 5 ¥ 10
7 cfu S. pneumoniae D39 or PLN, and whole lung homogenates were obtained 6 h later. Data are means
 SEM (n = 8 per group).
*P < 0.05 versus WT mice. **P < 0.001 versus WT mice. ***P < 0.01 versus WT mice.
TNF-a, IL-1b, IL-10, MIP-2 and KC values are in pg ml
-1; cfu values are in cfu ml
-1 lung; MPO levels are in mgm l
-1; TLIS (total lung inﬂammation
score) in arbitrary units.
BD, below detection limit.
Fig. 4. Reduced lung inﬂammation in TLR2 KO mice early after infection with S. pneumoniae D39 or S. pneumoniae PLN. Representative
lung tissue slides from WT mice (A and C) and TLR2 KO mice (B and D) 6 h after infection with 5 ¥ 10
7 cfu S. pneumoniae D39 (A and B) or
S. pneumoniae PLN (C and D). HE staining: magniﬁcation 4¥. Insets show Ly-6G staining.
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upper airway colonization (Malley et al., 2003; Srivastava
et al., 2005) and to a lesser extent during experimental
lower respiratory tract infection (Branger et al., 2004).
Although the pneumococcus expresses several potent
TLR2 ligands (Yoshimura et al., 1999; Han et al., 2003;
Schroder et al., 2003), our laboratory previously could not
demonstrate a decisive role for TLR2 in host defence
against pneumococcal pneumonia (Knapp et al., 2004).
We here hypothesized that in the absence of TLR2,
S. pneumoniae could still be sensed by the immune
system through an interaction between pneumolysin and
TLR4. The experiments described herein support this
hypothesis: whereas the growth of WT pneumococci
occurred to a similar extent in TLR2 KO and WT mice, the
pneumolysin-deﬁcient S. pneumoniae PLN strain only
grew out in TLR2 KO mice. These data suggest that
pneumolysin-induced TLR4 signalling can compensate
for TLR2 deﬁciency during respiratory tract infection with
S. pneumoniae.
In a series of elegant experiments Malley and cowork-
ers demonstrated that pneumolysin is a ligand for TLR4
(Malley et al., 2003; Srivastava et al., 2005). Puriﬁed
pneumolysin was shown to activate cells via a TLR4-
dependent, TLR2-independent pathway, accomplished by
a physical interaction between pneumolysin and TLR4
(Malley et al., 2003; Srivastava et al., 2005). Interestingly,
pneumolysin induced proinﬂammatory responses in
primary macrophages in synergy with TLR2 ligands
derived from S. pneumoniae, in particular peptidoglycan
and whole pneumococcal cell walls (Malley et al., 2003;
Srivastava et al., 2005), suggesting that during infection
with intact pneumococci, the combined action of TLR4
and TLR2 may facilitate an optimal innate immune
response. Such roles for these two distinct TLRs is further
corroborated by ﬁndings that, in the human embryonic
kidney cell line 293, transfection of either TLR2 or TLR4
conferred responsiveness to S. pneumoniae (Koedel
et al., 2003). Thus far, the isolated roles of either TLR4 or
TLR2 in host defence against S. pneumoniae in vivo have
been investigated in a number of studies. The most dra-
matic phenotype was reported in the original publication
by Malley et al. (Malley et al., 2003; Srivastava et al.,
2005), showing that C3H/HeJ mice, which carry a loss-of-
function tlr4 mutation, are more susceptible to pneumo-
coccal colonization after nasopharyngeal challenge,
eventually resulting in invasive infection, bacteremia and
death. Our laboratory found a more modest protective role
for TLR4 during lower respiratory tract infection by
S. pneumoniae, as reﬂected by a reduced survival and a
slightly enhanced bacterial outgrowth after intranasal
infection of C3H/HeJ mice with a relatively low infectious
dose (Branger et al., 2004). TLR2 KO mice demonstrated
an increased disease severity together with a moderately
enhanced bacterial growth in the central nervous system
during meningitis induced by intracisternal injection of
pneumococci (Echchannaoui et al., 2002; Koedel et al.,
2003). In contrast, our group could not demonstrate a
protective role for TLR2 in pneumonia caused by
S. pneumoniae, showing similar bacterial multiplication
and lethality after intranasal infection of TLR2 KO and WT
mice (Knapp et al., 2004). A limited role for TLR2 during
infection with WT S. pneumoniae is further supported by a
recent study in which intact pneumococci were adminis-
tered intraperitoneally (Khan et al., 2005), although TLR2
KO mice displayed a modestly slower clearance of
S. pneumoniae from their nasopharynx in another inves-
tigation (van Rossum et al., 2005). Altogether these
studies suggest that TLR2 at best plays a modest role in
host defence against S. pneumoniae airway infection, and
led us to hypothesize that intact TLR4 signalling through
pneumolysin may balance the lack of TLR2 signalling. We
tested this hypothesis by infecting TLR2 KO mice with
pneumolysin-deﬁcient S. pneumoniae, arguing that these
bacteria, devoid of a major TLR4 ligand, predominantly
express TLR2 ligands. Indeed, whereas antibacterial
defence in TLR2 KO mice was unimpaired during infection
with S. pneumoniae D39, infection with S. pneumoniae
PLN resulted in enhanced outgrowth in these mice. If our
hypothesis is correct, inoculation of WT S. pneumoniae
D39 in TLR2 ¥ 4 double KO mice should result in a com-
parable setting as pneumolysin-deﬁcient S. pneumoniae
in TLR2 KO mice, i.e. absence of TLR2 and TLR4
signalling. Our ﬁrst preliminary results show that indeed
this is the case: growth of WT S. pneumoniae D39 was
signiﬁcantly higher in the lungs of TLR2 ¥ 4 double KO
mice compared with WT mice 48 h after inoculation (data
not shown). In line, Albiger et al. (2005) recently showed
that mice deﬁcient of the TLR2- and TLR4-common intra-
cellular adaptor molecule MyD88 also displayed an
enhanced bacterial outgrowth in MyD88 KO mice com-
pared with WT mice.
The early inﬂammatory response is an essential com-
ponent of host defence in this model of pneumococcal
pneumonia, as documented by previous studies in which
the early cytokine response was inhibited (van der Poll
et al., 1997; Rijneveld et al., 2001). Although TLR2 KO
mice displayed a reduced inﬂammatory response 6 h after
infection with either S. pneumoniae D39 or PLN, some
responses were more strongly diminished after infection
with the pneumolysin-deﬁcient strain. This was in particu-
lar true for the early TNF-a response. Considering that
especially low TNF-a concentrations in the lungs early
after induction of pneumococcal pneumonia are important
for limiting the growth of S. pneumoniae (van der Poll
et al., 1997; Rijneveld et al., 2001), this differential
response may have contributed to the enhanced growth
of S. pneumoniae PLN in TLR2 KO mice. In addition,
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tribute to this ﬁnding. Of note, TLR2 KO mice still display
an induction of cytokines and chemokines when infected
with pneumolysin-deﬁcient S. pneumoniae, suggesting
that other pattern recognition receptors contribute to this
response, In this respect, the recent ﬁnding that TLR9 can
recognize pneumococcall DNAis of relevance (Mogensen
et al., 2006). Moreover, although histopathological analy-
sis of lung tissue showed diminished lung inﬂammation in
TLR2 KO mice during the early course of infection with
S. pneumoniae PLN, which is in line with a TLR2-
dependent immune response, during the later phase of
pneumonia lung inﬂammation of TLR2 KO mice was
enhanced compared with WT mice, which corresponded
with the higher bacterial loads. This ﬁnding suggests that,
in the presence of a high bacterial burden, S. pneumoniae
PLN is able to elicit signiﬁcant lung inﬂammation via a
TLR2-independent route. Hence, it is conceivable that the
early recognition of S. pneumoniae and, thereby, the initial
inﬂammatory response in the airways at least in part are
mediated by TLR2, through an interaction between this
receptor and the various TLR2 ligands expressed by the
pneumococcus (Yoshimura et al., 1999; Han et al., 2003;
Schroder et al., 2003), but that, during a more established
infection with a higher bacterial burden, the TLR2-induced
inﬂammation is ‘overruled’ by other pathways stimulated
by TLR2-independent pneumococcal antigens.
Our results exemplify the complex interactions at play
during the ﬁrst encounter between the host, expressing
multiple pattern recognition receptors, and an intact
pathogen, expressing multiple virulence factors and
pathogen-associated molecular patterns. Whereas during
infection of TLR2 KO mice with WT pneumococci, the
interaction between TLR4 and pneumolysin apparently is
sufficient to maintain an adequate immune response,
during infection of TLR2 KO mice with pneumolysin-
deﬁcient S. pneumoniae, the absence of the interaction
between pneumococcal TLR2 ligands, such as lipote-
ichoic acid and peptidoglycan, cannot be compensated
for by the TLR4 pneumolysin-mediated immune
response. As such, our data demonstrate redundancy at
both the microbial site and the site of the host during
airway infection by S. pneumoniae.
Experimental procedures
Animals
C57BL/6 WT mice were purchased from Charles Rivers (Maas-
tricht, the Netherlands). TLR2 KO mice (Takeuchi et al., 1999),
backcrossed to a C57BL/6 genetic background six times, were
bred in the animal facility of the Academic Medical Center in
Amsterdam. Sex- and age-matched (10–12 weeks) mice were
used in all experiments. All experiments were approved by the
Animal Care and Use Committee of the University ofAmsterdam.
Design
The experimental procedures to induce pneumonia have been
described earlier (Branger et al., 2004; Knapp et al., 2004;
Dessing et al., 2007). S. pneumoniae serotype 2 (strain D39) and
isogenic pneumolysin-deﬁcient S. pneumoniae (strain PLN)
(Berry et al., 1989) were grown for 5 h to mid-logarithmic phase
at 37°C using Todd–Hewitt broth (Difco, Detroit, MI), harvested by
centrifugation at 1500 g for 15 min, and washed twice in sterile
isotonic saline. A total of 50 ml containing 5 ¥ 10
7 colony-forming
units (cfu) were inoculated intranasally in mice which were lightly
anesthetized by inhalation of isoﬂurane (Upjohn, Ede, the
Netherlands). Mice were killed 6, 24 or 48 h after infection with
S. pneumoniae D39, or 6, 24, 48 or 72 h after infection with
S. pneumoniae PLN. In separate studies, survival of mice was
determined during a 2 week follow-up.
Measurement of bacterial loads
Lung bacterial loads were determined as described earlier
(Branger et al., 2004; Knapp et al., 2004; Dessing et al., 2007).
Brieﬂy, mice were sacriﬁced, and blood and lungs were collected.
Lungs were homogenized at 4°C in 5 vols of sterile isotonic saline
with a tissue homogenizer (Biospect Products, Bartlesville, OK).
Serial 10-fold dilutions in sterile isotonic saline were made from
these homogenates (and blood), and 50 ml vols were plated onto
sheep-blood agar plates and incubated overnight at 37°C and 5%
CO2.
Histology
Lungs for histology were ﬁxed in 10% formalin and embedded in
paraffin. Four millimetre sections were stained with haematoxylin
and eosin (HE) and analysed by a pathologist who was blinded
for groups. To score lung inﬂammation and damage, the entire
lung surface was analysed with respect to the following param-
eters: bronchitis, oedema, interstitial inﬂammation, intra-alveolar
inﬂammation, pleuritis and endothelialitis. Each parameter was
graded on a scale of 0–4, with 0 as ‘absent’ and 4 as ‘severe’.
The total ‘lung inﬂammation score’ was expressed as the sum of
the scores for each parameter, the maximum being 24. Granu-
locyte staining was performed as described earlier by Ly-6G
staining (Dessing et al., 2007).
Assays
Lung homogenates were prepared as described earlier (Knapp
et al., 2004). MPO was measured by ELISA (HyCult, Uden, the
Netherlands). TNF-a,I L - 1 b, IL-10, MIP-2 and KC were measured
by ELISA (R and D Systems, Abingdon, UK).
Statistical analysis
Statistics were performed with GraphPad Prism version 4.00 for
Windows (GraphPad Software, San Diego, CA). All data are
given as means  SEM. Differences between groups were analy-
sed using Mann–Whitney U-test. For survival analyses, Kaplan-
Meier analysis followed by log rank test was performed. To
analyse the effect of the used bacterial strains and their interac-
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tion, results of the groups were compared using an ANOVA. Data
were checked for normal distribution and equal variances using
the residuals. All variables were normally distributed, but MIP-2,
IL-1b and TNF-a were ln-transformed to obtain equal variances.
Later statistics was performed using SPSS statistical software
version 12.0.1 (SPSS, Chicago, IL). A value of P < 0.05 was
considered statistically signiﬁcant.
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